| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/11/2007 | EP1771193A1 Gus3 neuropeptides for regulating hypothalamic function |
| 04/11/2007 | EP1771192A2 Use of aspartate for regulating glucose levels in blood |
| 04/11/2007 | EP1771191A2 Preparation for use of aspartate and vitamin b12 or biotin for regulating ketone bodies |
| 04/11/2007 | EP1771190A2 Method of producing fully carbamylated erythropoietin |
| 04/11/2007 | EP1771189A2 Methods of treating type i diabetes by blocking vegf-mediated activity |
| 04/11/2007 | EP1771153A1 Composition for delivery of an active agent |
| 04/11/2007 | EP1592476B1 Methods for the purification of stable radioiodine conjugates |
| 04/11/2007 | EP1515990B1 Antagonists of cxcr3-binding cxc chemokines |
| 04/11/2007 | EP1511768B1 Immunogenic compositions |
| 04/11/2007 | EP1511759A4 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof. |
| 04/11/2007 | EP1483283A4 Modulation of protein methylation and phosphoprotein phosphate |
| 04/11/2007 | EP1471930B1 Use of erythropoietin for the preventive or curative treatment of cardiac failure |
| 04/11/2007 | EP1435985B1 Medicament containing activated antithrombin iii |
| 04/11/2007 | EP1414458B1 Oral administration of 6-hydroxy-oxymorphone for use as an analgesic |
| 04/11/2007 | EP1353952B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 04/11/2007 | EP1341767B1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 04/11/2007 | EP1307237B1 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof |
| 04/11/2007 | EP1054894B1 Breast cancer resistance protein (bcrp) and the dna which encodes it |
| 04/11/2007 | EP1054683B1 Modified heat shock protein-antigenic peptide complex |
| 04/11/2007 | EP1021197B1 Implants comprising combinations of allogeneic cells for use in cancer treatment |
| 04/11/2007 | EP1015439B1 Prenyl transferase inhibitors |
| 04/11/2007 | EP1012191B1 Method for obtaining high-purity vwf or factor viii/vwf complex |
| 04/11/2007 | EP1005492B1 Purification of von willebrand factor by cation exchanger chromatography |
| 04/11/2007 | EP0988379B1 Ldl-receptor |
| 04/11/2007 | EP0984987B1 A soluble laminin receptor precursor and methods to ihnibit its interactions |
| 04/11/2007 | EP0961780B1 Protein markers for lung cancer and use thereof |
| 04/11/2007 | EP0755407B1 Pharmaceutical peptide formulations for treatment of dust mite allergy |
| 04/11/2007 | EP0741748B1 Monoclonal antibodies specific to vegf receptors and uses thereof |
| 04/11/2007 | CN1946742A Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination |
| 04/11/2007 | CN1946734A Compositions and methods for the systemic treatment of arthritis |
| 04/11/2007 | CN1946720A Azabenzofuran substituted thioureas; inhibitors of viral replication |
| 04/11/2007 | CN1946718A Novel ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus |
| 04/11/2007 | CN1946692A 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine protease |
| 04/11/2007 | CN1946691A Novel compounds as inhibitors of hepatitis C virus NS3 serine protease |
| 04/11/2007 | CN1946452A Frequency assisted transdermal agent delivery method and system |
| 04/11/2007 | CN1946427A Liquid growth hormone formulation |
| 04/11/2007 | CN1946423A Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 04/11/2007 | CN1946419A Use of aerosolized antithrombin to treat acute lung injury |
| 04/11/2007 | CN1946418A Treatment of conditions involving dopaminergic neuronal degeneration using NOGO receptor antagonists |
| 04/11/2007 | CN1946417A Inhibitors of type 2 vascular endothelial growth factor receptors |
| 04/11/2007 | CN1946416A Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window |
| 04/11/2007 | CN1946388A Therapeutic methods employing nitric oxide precursors |
| 04/11/2007 | CN1944651A Bacterial strain, gene and enzyme for preventing bacterial diseases by quenching mass induction signal |
| 04/11/2007 | CN1944645A Method for preparing recombinant human antithrombase III protein using mammary gland biological reactor |
| 04/11/2007 | CN1944463A Fusion protein with alpha-interferon activity and its coded gene and use |
| 04/11/2007 | CN1944460A Alr多肽及其应用 Alr peptide and its application |
| 04/11/2007 | CN1944459A Process for preparing placental polypeptide for injection |
| 04/11/2007 | CN1944458A Protein and small molecule polypeptide for increasing lysozyme bacteriolysis activity and its use |
| 04/11/2007 | CN1944457A Glutathione calcium chelate and its preparing method, use and composition |
| 04/11/2007 | CN1944456A Process for preparing duck wheat anti-tumor protein |
| 04/11/2007 | CN1943790A Prevention and treatment of restenosis by local administration of drug |
| 04/11/2007 | CN1943783A The preparation of compound digestive enzyme and its preparation method |
| 04/11/2007 | CN1943782A Medicament for treating avian influenza |
| 04/11/2007 | CN1943781A Orally administered peptides to ameliorate atherosclerosis |
| 04/11/2007 | CN1943780A The application of kallidinogen enzyme in preparation of the pharmaceutical used for treatment of tumor |
| 04/11/2007 | CN1943557A Process for preparing nano liposome for coating large molecular medicine |
| 04/11/2007 | CN1943556A Method for preparing protein and polypeptide medicine lisposome |
| 04/11/2007 | CN1943369A Collagen protein milk drink and its producing method |
| 04/11/2007 | CN1309833C Angiostatin and its use for preparing medicament |
| 04/11/2007 | CN1309830C Variants of TRAF2 which act as an inhibitor of TNF-alpha signaling pathway |
| 04/11/2007 | CN1309824C Antibiotic peptide gene converted viscons bacillus engineering bacterium and its preparing method and use |
| 04/11/2007 | CN1309737C Recombinant gelatins |
| 04/11/2007 | CN1309735C Soluble CTL A4 mutant molecules and use thereof |
| 04/11/2007 | CN1309734C Polypeptides involved in immune response |
| 04/11/2007 | CN1309733C Pepties from the 16/6id antibody for treating SLE |
| 04/11/2007 | CN1309423C Interferon gamma conjugates |
| 04/11/2007 | CN1309418C Immunostimulatory oligodeoxynucleotides |
| 04/11/2007 | CN1309417C Use of cell penetrating peptides to generate antitumor immunity |
| 04/11/2007 | CN1309416C Pharmaceutical composition |
| 04/11/2007 | CN1309415C Endoparasiticidal agent composition |
| 04/11/2007 | CN1309414C Hydrophilic binary systems for the administration of cyclosporine |
| 04/11/2007 | CN1309413C Tetrapeptide derivative crystals |
| 04/11/2007 | CN1309380C Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 04/10/2007 | US7202357 Hybrid nucleic acid; prevent gene expression; therapy for atherosclerosis, cardiovascular and metabolism disorders |
| 04/10/2007 | US7202351 Alteration of immune response using pan DR-binding peptides |
| 04/10/2007 | US7202347 used to diagnose and/or treat a wide variety of liver and other disorders (cancer) and tracing hepatocyte lineage; genetic engineering |
| 04/10/2007 | US7202345 PRO 1384 antibodies |
| 04/10/2007 | US7202341 Stabilized hemoglobin solutions |
| 04/10/2007 | US7202340 Administering modified hemoglobins comprising nitrosylhemoglobin, nitrosyl-heme, metal substituted heme iron, or nitrosyl-porphyrin; vasodilation; anticoagulants; synthetic blood |
| 04/10/2007 | US7202334 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 04/10/2007 | US7202333 Recombinant soluble fragment of the alpha-subunit polypeptide of human mast cell IgE surface receptor, capable of binding to human IgE; can be used in diagnostic, drug screening and antiallergen applications |
| 04/10/2007 | US7202332 Methods for preparing internally constrained peptides and peptidomimetics |
| 04/10/2007 | US7202331 For inducing immune response and administering immunotherapy |
| 04/10/2007 | US7202330 RGD (Arg-Gly-Asp) coupled to (neuro)peptides |
| 04/10/2007 | US7202279 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders |
| 04/10/2007 | US7202258 α- and β-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors |
| 04/10/2007 | US7202224 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 04/10/2007 | US7202218 Is able to specifically bind IL-6R and compete for the binding of IL-6 to IL-6R, to block IL-6-induced signal transduction and therefore effectively inhibits IL-6-mediated antiapoptosis and angiogenesis, and further inhibits IL-6-mediated tumor growth. |
| 04/10/2007 | US7202217 The result of PR-39 peptide interaction with proteasomes is a decrease in the intracellular degradation of active peptides such as HIF-1 alpha and a consequential stimulation of angiogenesis in-situ. |
| 04/10/2007 | US7202216 computer-assisted method for identifying potential modulators of Celiac Sprue and/or dermatitis herpetiformis, using a programmed computer |
| 04/10/2007 | US7202215 Long-acting follicle stimulating hormone analogues and uses thereof |
| 04/10/2007 | US7202214 Rhizoc3 antimicrobial polypeptides and their uses |
| 04/10/2007 | US7202213 Peroxisome Proliferator-Activated Receptor-alpha and Peroxisome Proliferator-Activated Receptor-gama activator and a Glucagon-Like Peptide-1; antidiabetic agents; insulin resistance; dyslipidemia; obesity; hypotensive agents |
| 04/10/2007 | US7202212 Proteasome mechanisms regulated by PR-39 peptides, selective inhibition of I kappa B alpha degradation on-demand and is used for controlled suppression of NF kappa B transcription factor activity and NF kappa B-dependent gene expression |
| 04/10/2007 | US7202211 Methods of preventing or treating brain ischemia or brain injury |
| 04/10/2007 | US7202210 Premature peptide for use in treatment of nervous system, muscular, heart, diabetic and bone disorders |
| 04/10/2007 | US7202209 Cyclosporin compositions |
| 04/10/2007 | US7202208 Erythropoietin composition |
| 04/10/2007 | US7202207 Infection therapy; binding of mannan lecithin to protein |
| 04/10/2007 | US7202080 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway |